EGFR mutations and consequent overexpression are frequent in GBM, with a majority of GBM containing the constitutively active mutant EGFR, which shows a genetic deletion of exon 2–7 and is named EGFRvIII (Heimberger et al., 2005; Figure 4). Here, EGFR is linked to glioblastoma.